Information Notice 2003-22, Heightened Awareness for Patients Containing Detectable Amounts of Radiation from Medical Administrations: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(StriderTol Bot change)
 
Line 16: Line 16:
{{#Wiki_filter:UNITED STATES
{{#Wiki_filter:UNITED STATES


NUCLEAR REGULATORY COMMISSION
===NUCLEAR REGULATORY COMMISSION===
OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS


OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS
WASHINGTON, D.C.  20555-0001


WASHINGTON, D.C. 20555-0001 December 9, 2003 NRC INFORMATION NOTICE 2003-22:               HEIGHTENED AWARENESS FOR PATIENTS
===December 9, 2003===
NRC INFORMATION NOTICE 2003-22:


===HEIGHTENED AWARENESS FOR PATIENTS===
CONTAINING DETECTABLE AMOUNTS OF
CONTAINING DETECTABLE AMOUNTS OF


RADIATION FROM MEDICAL ADMINISTRATIONS
===RADIATION FROM MEDICAL ADMINISTRATIONS===


==Addressees==
==Addressees==
Line 40: Line 43:
In reviewing this notice, licensees are also reminded to emphasize to those patients still
In reviewing this notice, licensees are also reminded to emphasize to those patients still


containing detectable amounts of radiation from medical administrations and released with
containing detectable amounts of radiation from medical administrations and released with


written instructions in accordance with 10 CFR 35.75, the importance of following those
written instructions in accordance with 10 CFR 35.75, the importance of following those


instructions. This is essential for maintaining doses to other individuals as low as is reasonable
instructions. This is essential for maintaining doses to other individuals as low as is reasonable


achievable and, presently, to reduce the occurrence of patients triggering with radiation
achievable and, presently, to reduce the occurrence of patients triggering with radiation
Line 52: Line 55:
It is expected that recipients will review this information for applicability to their licensed
It is expected that recipients will review this information for applicability to their licensed


operations and consider actions, as appropriate, to avoid similar problems. However, suggestions contained in this IN are not new NRC requirements; therefore, no specific action
operations and consider actions, as appropriate, to avoid similar problems. However, suggestions contained in this IN are not new NRC requirements; therefore, no specific action


nor written response is required.
nor written response is required.
Line 60: Line 63:
On March 20, 2003, a bus traveling from New York to Atlantic City set off a radiation alarm in a
On March 20, 2003, a bus traveling from New York to Atlantic City set off a radiation alarm in a


tunnel, as it passed by a radiation detector. When the State Police pulled over the bus, it was
tunnel, as it passed by a radiation detector. When the State Police pulled over the bus, it was


discovered that one of the passengers had received a 370 Megabecquerel (10 millicurie) dose
discovered that one of the passengers had received a 370 Megabecquerel (10 millicurie) dose


of iodine-131 earlier that day from a medical procedure. Although the medical licensee
of iodine-131 earlier that day from a medical procedure. Although the medical licensee


provided the patient with written safety instructions, which included not using public
provided the patient with written safety instructions, which included not using public


transportation for 2 days, the patient failed to follow the instructions. This resulted in the
transportation for 2 days, the patient failed to follow the instructions. This resulted in the


activation of the radiation detector in the tunnel. Subsequent discussions with the patients
activation of the radiation detector in the tunnel. Subsequent discussions with the patients


physician indicated that the patients actions in taking the trip would have no safety significance
physician indicated that the patients actions in taking the trip would have no safety significance


to the members of the public on or near the bus. However, the event resulted in unnecessary
to the members of the public on or near the bus. However, the event resulted in unnecessary


concern and inconvenience to the patient and members of the public, as well as to law
concern and inconvenience to the patient and members of the public, as well as to law
Line 81: Line 84:


Discussion:
Discussion:
Heightened security measures are now in effect throughout the United States. These include, but are not limited to, installation of radiation surveillance equipment at critical infrastructures
Heightened security measures are now in effect throughout the United States. These include, but are not limited to, installation of radiation surveillance equipment at critical infrastructures


and mass congregation events. Therefore, types of incidents such as the one described within
and mass congregation events. Therefore, types of incidents such as the one described within


this IN are likely to increase for released patients that still contain detectable amounts of
this IN are likely to increase for released patients that still contain detectable amounts of
Line 93: Line 96:
instructions, when released in accordance with 10 CFR 35.75, but could also include patients
instructions, when released in accordance with 10 CFR 35.75, but could also include patients


administered diagnostic dosages or low-level therapeutic dosages of radiopharmaceuticals. In
administered diagnostic dosages or low-level therapeutic dosages of radiopharmaceuticals. In


the example above, if the patient had been administered less than 259 Megabecquerel
the example above, if the patient had been administered less than 259 Megabecquerel
Line 107: Line 110:
with 10 CFR 35.75, the licensees are expected to, among other things, review with authorized
with 10 CFR 35.75, the licensees are expected to, among other things, review with authorized


users the expectation that written instructions provided to patients will be followed. Accordingly, authorized users are expected to evaluate the patients capability to follow recommended
users the expectation that written instructions provided to patients will be followed. Accordingly, authorized users are expected to evaluate the patients capability to follow recommended


written instructions before release, to determine if release at that time is advisable, and stress
written instructions before release, to determine if release at that time is advisable, and stress
Line 120: Line 123:


brachytherapy implants:
brachytherapy implants:
        1.     Released patients who are administered diagnostic or therapeutic quantities of
1.
 
Released patients who are administered diagnostic or therapeutic quantities of


radiopharmaceuticals or brachytherapy implants should be aware that their
radiopharmaceuticals or brachytherapy implants should be aware that their
Line 126: Line 131:
treatment may have additional implications, because of heightened security
treatment may have additional implications, because of heightened security


measures. Accordingly, provide all patients that still contain delectable amounts
measures. Accordingly, provide all patients that still contain delectable amounts


of radiation with an appropriate explanation about the potential of alarming
of radiation with an appropriate explanation about the potential of alarming
Line 132: Line 137:
radiation monitoring equipment.
radiation monitoring equipment.


2.     To assist the patient and avoid unnecessary concern by law enforcement
2.
 
To assist the patient and avoid unnecessary concern by law enforcement


authorities and other public officials, consider providing the patient with the
authorities and other public officials, consider providing the patient with the
Line 140: Line 147:
that the radiation received by the patient poses no danger to the public and that
that the radiation received by the patient poses no danger to the public and that


it is allowed by NRC medical use regulations. This IN requires no specific action nor written response. If you have any questions about the
it is allowed by NRC medical use regulations. This IN requires no specific action nor written response. If you have any questions about the


information in this notice, please contact one of the technical contacts listed below or the
information in this notice, please contact one of the technical contacts listed below or the
Line 147: Line 154:


/RA/
/RA/
                                              Charles L. Miller, Director


===Charles L. Miller, Director===
Division of Industrial and
Division of Industrial and


Line 157: Line 164:
and Safeguards
and Safeguards


Technical Contacts:     Teresa Darden, Region I              Pamela J. Henderson, Region I
Technical Contacts:


610-337-5245                         610-337-6952 E-mail: thd@nrc.gov                 E-mail: pjh1@nrc.gov
===Teresa Darden, Region I===
Pamela J. Henderson, Region I
 
610-337-5245
610-337-6952 E-mail: thd@nrc.gov
 
E-mail: pjh1@nrc.gov


Donna-Beth Howe, Ph.D., NMSS
Donna-Beth Howe, Ph.D., NMSS
Line 166: Line 179:


Attachments:
Attachments:
1. List of Recently Issued NRC Information Notices
1. List of Recently Issued NRC Information Notices


2. List of Recently Issued NMSS Information Notices This IN requires no specific action nor written response. If you have any questions about the
2. List of Recently Issued NMSS Information Notices This IN requires no specific action nor written response. If you have any questions about the


information in this notice, please contact one of the technical contacts listed below or the
information in this notice, please contact one of the technical contacts listed below or the
Line 175: Line 188:


/RA/
/RA/
                                              Charles L. Miller, Director


===Charles L. Miller, Director===
Division of Industrial and
Division of Industrial and


Line 185: Line 198:
and Safeguards
and Safeguards


Technical Contacts:     Teresa Darden, Region I               Pamela J. Henderson, Region I
Technical Contacts:
 
===Teresa Darden, Region I===
Pamela J. Henderson, Region I
 
610-337-5245
610-337-6952 E-mail: thd@nrc.gov


610-337-5245                          610-337-6952 E-mail: thd@nrc.gov                    E-mail: pjh1@nrc.gov
E-mail: pjh1@nrc.gov


Donna-Beth Howe, Ph.D., NMSS
Donna-Beth Howe, Ph.D., NMSS
Line 194: Line 213:


Attachments:
Attachments:
1. List of Recently Issued NRC Information Notices
1. List of Recently Issued NRC Information Notices


2. List of Recently Issued NMSS Information Notices
2. List of Recently Issued NMSS Information Notices


ADAMS Accession#:
ADAMS Accession#:
Document Name: G:\IMNS\Cabrera\IN-R1 Inst. to Patients.wpd
Document Name: G:\\IMNS\\Cabrera\\IN-R1 Inst. to Patients.wpd


* See previous concurrence or e-mail
* See previous concurrence or e-mail


OFFICE:     DNMS/R-I         MSIB       MSIB           NMSS          MSIB        IMNS
OFFICE:
DNMS/R-I
 
MSIB
 
MSIB


NAME:      PHenderson*      ICabrera*    Ekraus(fax)*    RTorres*      TEssig*      CMiller
NMSS


DATE:          8 /19/03        8 /19/03    8/25/03      8/ 29 /03      9 / 2 /03    12/4/03 OFFICIAL RECORD COPY
MSIB


Attachment 1 LIST OF RECENTLY ISSUED
IMNS


NAME:
PHenderson*
ICabrera*
Ekraus(fax)*
RTorres*
TEssig*
CMiller
DATE:
    8 /19/03
  8 /19/03
  8/25/03
8/ 29 /03
  9 / 2 /03
  12/4/03
===OFFICIAL RECORD COPY===
______________________________________________________________________________________
OL = Operating License
CP = Construction Permit
===Attachment 1 LIST OF RECENTLY ISSUED===
NRC INFORMATION NOTICES
NRC INFORMATION NOTICES


_____________________________________________________________________________________
_____________________________________________________________________________________
Information                                             Date of
Information


Notice No.             Subject                         Issuance         Issued to
Date of
 
Notice No.
 
Subject
 
Issuance
 
Issued to


_____________________________________________________________________________________
_____________________________________________________________________________________
2003-21           High-Dose-Rate-Remote-               Pending           All medical licensees.
2003-21 High-Dose-Rate-Remote-
 
===Afterloader Equipment Failure===
Pending
 
All medical licensees.


Afterloader Equipment Failure
2003-20


2003-20          Derating Whiting Cranes             10/22/2003       All holders of operating licenses
===Derating Whiting Cranes===
Purchased Before 1980
10/22/2003


Purchased Before 1980                                  for nuclear power reactors, except those who have
===All holders of operating licenses===
for nuclear power reactors, except those who have


permanently ceased operations
permanently ceased operations
Line 241: Line 305:
fuel storage installations.
fuel storage installations.


2003-19           Unanalyzed Condition of             10/06/2003       All holders of operating licenses
2003-19
 
===Unanalyzed Condition of===
Reactor Coolant Pump Seal
 
===Leakoff Line During Postulated===
Fire Scenarios or Station
 
Blackout
 
10/06/2003
 
===All holders of operating licenses===
or construction permits for


Reactor Coolant Pump Seal                              or construction permits for
pressurized water reactors


Leakoff Line During Postulated                        pressurized water reactors
(PWRs).


Fire Scenarios or Station                              (PWRs).
2003-18


Blackout
===General Electric Type SBM===
Control Switches With
 
Defective Cam Followers


2003-18          General Electric Type SBM            09/26/2003       All holders of operating licenses
09/26/2003


Control Switches With                                  for nuclear power reactors, Defective Cam Followers                                except those who have
===All holders of operating licenses===
for nuclear power reactors, except those who have


permanently ceased operations
permanently ceased operations
Line 263: Line 344:
the reactor vessel.
the reactor vessel.


2003-17           Reduced Service Life of              09/29/2003        All holders of operating licenses
2003-17


Automatic Switch Company                               for nuclear power reactors.
===Reduced Service Life of===
Automatic Switch Company


(ASCO) Solenoid Valves With
(ASCO) Solenoid Valves With
Line 271: Line 353:
Buna-N Material
Buna-N Material


2003-16          Icing Conditions Between            10/06/2003       All 10 CFR Part 72 licensees and
09/29/2003
 
===All holders of operating licenses===
for nuclear power reactors.
 
2003-16


Bottom of Dry Storage System                           certificate holders.
===Icing Conditions Between===
Bottom of Dry Storage System


and Storage Pad
and Storage Pad


Note:           NRC generic communications may be received in electronic format shortly after they are
10/06/2003
 
===All 10 CFR Part 72 licensees and===
certificate holders.
 
Note:
NRC generic communications may be received in electronic format shortly after they are


issued by subscribing to the NRC listserver as follows:
issued by subscribing to the NRC listserver as follows:
                To subscribe send an e-mail to <listproc@nrc.gov >, no subject, and the following
To subscribe send an e-mail to <listproc@nrc.gov >, no subject, and the following


command in the message portion:
command in the message portion:
                                  subscribe gc-nrr firstname lastname
subscribe gc-nrr firstname lastname


______________________________________________________________________________________
______________________________________________________________________________________
Line 290: Line 384:
CP = Construction Permit
CP = Construction Permit


Attachment 2 LIST OF RECENTLY ISSUED
===Attachment 2 LIST OF RECENTLY ISSUED===
 
NMSS INFORMATION NOTICES
NMSS INFORMATION NOTICES


_____________________________________________________________________________________
_____________________________________________________________________________________
Information                                               Date of
Information


Notice No.               Subject                           Issuance       Issued to
Date of
 
Notice No.
 
Subject
 
Issuance
 
Issued to


_____________________________________________________________________________________
_____________________________________________________________________________________
2003-21           High-Dose-Rate-Remote-                 Pending        All medical licensees.
2003-21 High-Dose-Rate-Remote-


Afterloader Equipment Failure
===Afterloader Equipment Failure===
Pending


2003-20            Derating Whiting Cranes                10/22/2003      All holders of operating licenses
All medical licensees.


Purchased Before 1980                                 for nuclear power reactors, except those who have
2003-20
 
===Derating Whiting Cranes===
Purchased Before 1980
10/22/2003
 
===All holders of operating licenses===
for nuclear power reactors, except those who have


permanently ceased operations
permanently ceased operations
Line 322: Line 431:
fuel storage installations.
fuel storage installations.


2003-16           Icing Conditions Between              10/06/2003      All 10 CFR Part 72 licensees and
2003-16


Bottom of Dry Storage System                           certificate holders.
===Icing Conditions Between===
Bottom of Dry Storage System


and Storage Pad
and Storage Pad


2003-12            Problems Involved in                  08/22/2003     All holders of 10 CFR Parts 32, Monitoring Dose to the Hands                          33, and 35 licenses.
10/06/2003
 
===All 10 CFR Part 72 licensees and===
certificate holders.


Resulting from the Handling of
2003-12


===Problems Involved in===
Monitoring Dose to the Hands
===Resulting from the Handling of===
Radiopharmaceuticals
Radiopharmaceuticals


2003-10            Criticality Monitoring System          08/04/2003     All U.S. Nuclear Regulatory
08/22/2003 All holders of 10 CFR Parts 32,
33, and 35 licenses.


Degradation at BWX                                    Commission (NRC) licensees
2003-10


Technologies, Inc., Nuclear                            authorized to possess a critical
===Criticality Monitoring System===
Degradation at BWX


Products Division, Lynchburg,                         mass of special nuclear material.
===Technologies, Inc., Nuclear===
Products Division, Lynchburg, VA


VA
08/04/2003


2003-09            Source Positioning Errors and          07/16/2003      All medical licensees.
===All U.S. Nuclear Regulatory===
Commission (NRC) licensees


authorized to possess a critical
mass of special nuclear material.
2003-09
===Source Positioning Errors and===
System Malfunctions During
System Malfunctions During


Administration of Intravascular
===Administration of Intravascular===
Brachtherapy


Brachtherapy
07/16/2003 All medical licensees.


Note:   NRC generic communications may be received in electronic format shortly after they are issued by
Note:
NRC generic communications may be received in electronic format shortly after they are issued by


subscribing to the NRC listserver as follows:
subscribing to the NRC listserver as follows:
        To subscribe send an e-mail to <listproc@nrc.gov >, no subject, and the following command in the
To subscribe send an e-mail to <listproc@nrc.gov >, no subject, and the following command in the


message portion:
message portion:
                                      subscribe gc-nrr firstname lastname
subscribe gc-nrr firstname lastname}}
 
______________________________________________________________________________________
OL = Operating License
 
CP = Construction Permit}}


{{Information notice-Nav}}
{{Information notice-Nav}}

Latest revision as of 06:15, 16 January 2025

Heightened Awareness for Patients Containing Detectable Amounts of Radiation from Medical Administrations
ML033390164
Person / Time
Issue date: 12/09/2003
From: Chris Miller
Office of Nuclear Material Safety and Safeguards
To:
Darden T, Howe D, Henderson P
References
IN-03-022
Download: ML033390164 (8)


UNITED STATES

NUCLEAR REGULATORY COMMISSION

OFFICE OF NUCLEAR MATERIAL SAFETY AND SAFEGUARDS

WASHINGTON, D.C. 20555-0001

December 9, 2003

NRC INFORMATION NOTICE 2003-22:

HEIGHTENED AWARENESS FOR PATIENTS

CONTAINING DETECTABLE AMOUNTS OF

RADIATION FROM MEDICAL ADMINISTRATIONS

Addressees

All medical licensees and NRC Master Materials License medical use permittees.

Purpose

The U.S. Nuclear Regulatory Commission (NRC) is issuing this Information Notice (IN) to alert

addressees of an event where a radiation detector, installed as part of heightened homeland

security measures, alarmed when a recently released radiopharmaceutical patient passed by it.

In reviewing this notice, licensees are also reminded to emphasize to those patients still

containing detectable amounts of radiation from medical administrations and released with

written instructions in accordance with 10 CFR 35.75, the importance of following those

instructions. This is essential for maintaining doses to other individuals as low as is reasonable

achievable and, presently, to reduce the occurrence of patients triggering with radiation

monitors, installed at public locations for increasing public security in the United States.

It is expected that recipients will review this information for applicability to their licensed

operations and consider actions, as appropriate, to avoid similar problems. However, suggestions contained in this IN are not new NRC requirements; therefore, no specific action

nor written response is required.

Description of Circumstances

On March 20, 2003, a bus traveling from New York to Atlantic City set off a radiation alarm in a

tunnel, as it passed by a radiation detector. When the State Police pulled over the bus, it was

discovered that one of the passengers had received a 370 Megabecquerel (10 millicurie) dose

of iodine-131 earlier that day from a medical procedure. Although the medical licensee

provided the patient with written safety instructions, which included not using public

transportation for 2 days, the patient failed to follow the instructions. This resulted in the

activation of the radiation detector in the tunnel. Subsequent discussions with the patients

physician indicated that the patients actions in taking the trip would have no safety significance

to the members of the public on or near the bus. However, the event resulted in unnecessary

concern and inconvenience to the patient and members of the public, as well as to law

enforcement authorities and other public officials.

Discussion:

Heightened security measures are now in effect throughout the United States. These include, but are not limited to, installation of radiation surveillance equipment at critical infrastructures

and mass congregation events. Therefore, types of incidents such as the one described within

this IN are likely to increase for released patients that still contain detectable amounts of

radiation from medical administrations of radiopharmaceuticals and brachytherapy sources.

These incidents may not be limited to those patients who are required to be provided written

instructions, when released in accordance with 10 CFR 35.75, but could also include patients

administered diagnostic dosages or low-level therapeutic dosages of radiopharmaceuticals. In

the example above, if the patient had been administered less than 259 Megabecquerel

(7 millicurie) of iodine-131, NRC regulations would not have required that the licensee provide

the patient with written instructions, but the patient might still have set off a radiation detection

alarm.

When licensees are required to provide written directions to patients released in accordance

with 10 CFR 35.75, the licensees are expected to, among other things, review with authorized

users the expectation that written instructions provided to patients will be followed. Accordingly, authorized users are expected to evaluate the patients capability to follow recommended

written instructions before release, to determine if release at that time is advisable, and stress

the importance to the patient of following the written instructions.

In view of the event described and its potential for becoming more common, licensees should

consider the following voluntary actions for all patients who still contain detectable amounts of

radiation after receiving diagnostic or therapeutic quantities of radiopharmaceuticals or

brachytherapy implants:

1.

Released patients who are administered diagnostic or therapeutic quantities of

radiopharmaceuticals or brachytherapy implants should be aware that their

treatment may have additional implications, because of heightened security

measures. Accordingly, provide all patients that still contain delectable amounts

of radiation with an appropriate explanation about the potential of alarming

radiation monitoring equipment.

2.

To assist the patient and avoid unnecessary concern by law enforcement

authorities and other public officials, consider providing the patient with the

licensees business card and written information for law enforcement use, stating

that the radiation received by the patient poses no danger to the public and that

it is allowed by NRC medical use regulations. This IN requires no specific action nor written response. If you have any questions about the

information in this notice, please contact one of the technical contacts listed below or the

appropriate regional office.

/RA/

Charles L. Miller, Director

Division of Industrial and

Medical Nuclear Safety

Office of Nuclear Material Safety

and Safeguards

Technical Contacts:

Teresa Darden, Region I

Pamela J. Henderson, Region I

610-337-5245

610-337-6952 E-mail: thd@nrc.gov

E-mail: pjh1@nrc.gov

Donna-Beth Howe, Ph.D., NMSS

301-415-7848 E-mail: dbh@nrc.gov

Attachments:

1. List of Recently Issued NRC Information Notices

2. List of Recently Issued NMSS Information Notices This IN requires no specific action nor written response. If you have any questions about the

information in this notice, please contact one of the technical contacts listed below or the

appropriate regional office.

/RA/

Charles L. Miller, Director

Division of Industrial and

Medical Nuclear Safety

Office of Nuclear Material Safety

and Safeguards

Technical Contacts:

Teresa Darden, Region I

Pamela J. Henderson, Region I

610-337-5245

610-337-6952 E-mail: thd@nrc.gov

E-mail: pjh1@nrc.gov

Donna-Beth Howe, Ph.D., NMSS

301-415-7848 E-mail: dbh@nrc.gov

Attachments:

1. List of Recently Issued NRC Information Notices

2. List of Recently Issued NMSS Information Notices

ADAMS Accession#:

Document Name: G:\\IMNS\\Cabrera\\IN-R1 Inst. to Patients.wpd

  • See previous concurrence or e-mail

OFFICE:

DNMS/R-I

MSIB

MSIB

NMSS

MSIB

IMNS

NAME:

PHenderson*

ICabrera*

Ekraus(fax)*

RTorres*

TEssig*

CMiller

DATE:

8 /19/03

8 /19/03

8/25/03

8/ 29 /03

9 / 2 /03

12/4/03

OFFICIAL RECORD COPY

______________________________________________________________________________________

OL = Operating License

CP = Construction Permit

Attachment 1 LIST OF RECENTLY ISSUED

NRC INFORMATION NOTICES

_____________________________________________________________________________________

Information

Date of

Notice No.

Subject

Issuance

Issued to

_____________________________________________________________________________________

2003-21 High-Dose-Rate-Remote-

Afterloader Equipment Failure

Pending

All medical licensees.

2003-20

Derating Whiting Cranes

Purchased Before 1980

10/22/2003

All holders of operating licenses

for nuclear power reactors, except those who have

permanently ceased operations

and have certified that fuel has

been permanently removed from

the reactor vessel; applicable

decommissioning reactors, fuel

facilities, and independent spent

fuel storage installations.

2003-19

Unanalyzed Condition of

Reactor Coolant Pump Seal

Leakoff Line During Postulated

Fire Scenarios or Station

Blackout

10/06/2003

All holders of operating licenses

or construction permits for

pressurized water reactors

(PWRs).

2003-18

General Electric Type SBM

Control Switches With

Defective Cam Followers

09/26/2003

All holders of operating licenses

for nuclear power reactors, except those who have

permanently ceased operations

and have certified that fuel has

been permanently removed from

the reactor vessel.

2003-17

Reduced Service Life of

Automatic Switch Company

(ASCO) Solenoid Valves With

Buna-N Material

09/29/2003

All holders of operating licenses

for nuclear power reactors.

2003-16

Icing Conditions Between

Bottom of Dry Storage System

and Storage Pad

10/06/2003

All 10 CFR Part 72 licensees and

certificate holders.

Note:

NRC generic communications may be received in electronic format shortly after they are

issued by subscribing to the NRC listserver as follows:

To subscribe send an e-mail to <listproc@nrc.gov >, no subject, and the following

command in the message portion:

subscribe gc-nrr firstname lastname

______________________________________________________________________________________

OL = Operating License

CP = Construction Permit

Attachment 2 LIST OF RECENTLY ISSUED

NMSS INFORMATION NOTICES

_____________________________________________________________________________________

Information

Date of

Notice No.

Subject

Issuance

Issued to

_____________________________________________________________________________________

2003-21 High-Dose-Rate-Remote-

Afterloader Equipment Failure

Pending

All medical licensees.

2003-20

Derating Whiting Cranes

Purchased Before 1980

10/22/2003

All holders of operating licenses

for nuclear power reactors, except those who have

permanently ceased operations

and have certified that fuel has

been permanently removed from

the reactor vessel; applicable

decommissioning reactors, fuel

facilities, and independent spent

fuel storage installations.

2003-16

Icing Conditions Between

Bottom of Dry Storage System

and Storage Pad

10/06/2003

All 10 CFR Part 72 licensees and

certificate holders.

2003-12

Problems Involved in

Monitoring Dose to the Hands

Resulting from the Handling of

Radiopharmaceuticals

08/22/2003 All holders of 10 CFR Parts 32,

33, and 35 licenses.

2003-10

Criticality Monitoring System

Degradation at BWX

Technologies, Inc., Nuclear

Products Division, Lynchburg, VA

08/04/2003

All U.S. Nuclear Regulatory

Commission (NRC) licensees

authorized to possess a critical

mass of special nuclear material.

2003-09

Source Positioning Errors and

System Malfunctions During

Administration of Intravascular

Brachtherapy

07/16/2003 All medical licensees.

Note:

NRC generic communications may be received in electronic format shortly after they are issued by

subscribing to the NRC listserver as follows:

To subscribe send an e-mail to <listproc@nrc.gov >, no subject, and the following command in the

message portion:

subscribe gc-nrr firstname lastname